Neudle.com: dystonia parkinsonism

Neurology Specific Literature Search

Differential
(Click to cross reference)

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome-related complex

adolescent medicine

advances in neurology

adverse drug reaction

akinesia of eyelid function

alien hand syndrome

alternating hemiplegia

alternating hemiplegia of childhood

Alzheimer's disease

anti basal ganglia antibodies

anticholinergic drugs

aphasia, progressive, primary

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

arm swing, reduced

ataxia, cerebellar

ataxia, progressive

athetosis, causes of

attention deficit disorder with hyperactivity

autoimmune basal ganglia encephalitis

autoimmune disease

autonomic dysfunction

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

bent spine syndrome

beta adrenergic blocker

biologic markers

biopterin deficiency

blinking, reduced

botulinum toxin

bradykinesia, facial

Brueghel's syndrome

calcification, intracranial

calcium antagonist

calcium antagonist, side effects of

carbon monoxide poisoning

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, isodense lesion with acute hemorrhage

CAT scan, muscle

central hypoventilation

central nervous system, infection of

cerebral cortical atrophy

cerebral ischemia

cerebral vasculature, calcification

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular accident, complications with

ceruloplasmin, serum

chorea, causes of

choreoathetosis

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cogwheel rigidty

comprehension, impaired

compression fracture

conjugate gaze, forced

contractures, joint

convergence, impaired

conversion reaction

copper metabolism, abnormal

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

crying, pathologic

cultured skin fibroblasts

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

developmental milestones, loss of

developmental retardation

dexterity, impaired

diagnostic criteria

differential diagnosis

disability, neurological

diurnal variation

dopa responsive dystonia

dopamine agonist

dopamine antagonist

drug induced neurologic disorders

drug withdrawal

dyskinesia, buccal lingual facial

dyskinesia, causes of

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, axial

dystonia, cervical

dystonia, children

dystonia, classification

dystonia, delayed onset

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, psychogenic

dystonia, treatment of

dystonic reaction, acute

emotional lability

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, viral

encephalopathy, progressive

epidemiology of neurology

exercise-induced neurologic dysfunction

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

fine motor function, impaired

frontal behavioral spatial syndrome

frontal lobe, atrophy

gamma amino butyric acid

gangliosidosis GM1

gaze palsy, supranuclear

gaze palsy, vertical

genetic counselling

genetic diagnosis, prenatal

genetic neurologic disorders

genetic testing

gests antagoniste

Gilles de la Tourette syndrome

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination, visual

hemifacial spasm

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatosplenomegaly

heralding manifestation

homovanillic acid

human immunodeficiency virus type 1

Huntington's chorea

hypometric saccades

hypoparathyroidism

iatrogenic neurologic disorders

ideomotor apraxia

imbalance, postural

inborn errors of metabolism

inclusion bodies, intranuclear

incontinence, fecal

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

Jakob-Creutzfeldt disease

jaw jerk, abnormal

Kayser-Fleischer ring

language disorder in adults

laughing, pathologic

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

leg spasms, painful

Leigh's disease

Lewy body disease, diffuse

lipid storage disorder of CNS

manganese intoxication

medical-legal aspects of neurology

memory, defect of recent

memory, impairment of

meningitis, carcinomatous

mental status, abnormal

metabolic disorder, primary

midbrain, atrophy

mitochondrial disease

molecular genetics

movement disorder

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI, CAT scan compared to

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, mouse ears

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis

multiple system atrophy

muscle spasm, face

muscle weakness

muscular dystrophy

myasthenia gravis

myoclonic jerks

myoclonus, segmental

myopathy, metabolic

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurodegeneration with brain iron accumulation

neuroendocrinology

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal intranuclear inclusion disease

neuroophthalmology

neurotransmitter

next-generation sequencing

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

nystagmus, monocular

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

ophthalmoplegia

optokinetic nystagmus, abnormal

paraplegia, in flexion

paraspinal muscle

paraspinal muscle weakness

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, juvenile

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, on-off phenomena in

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

paroxysmal nonkinesigenic dyskinesia

pathologic reflex

patient information and support

penguin silhouette sign

personality change

phenothiazine, dyskinesia associated with

phenylketonuria

pigmentary retinopathy

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

polycythemia, secondary

pons, lesion of

postural abnormality

precipitating factors

primary familial brain calcification

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

pseudobulbar palsy

pseudohypoparathyroidism

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

putamen, lesion of

putamen, lesion of, bilateral

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading problem, causes of

reflex sympathetic dystrophy

release phenomena

repetition, impaired

respirations in CNS disease

restless leg syndrome

retinal degeneration

retinitis pigmentosa

Rett's syndrome

reversible neurologic disorder

rigidity, axial

Riley-Day syndrome

saccadic eye movements, abnormal

salivation, excessive

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss, cortical

sequencing difficulty

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

spastic dysphonia

speech disorder

speech disorder, childhood

speech, loss of

status epilepticus

stimulation, deep brain

stimulation, thalamic

stooped posture

striatal encephalitis

striopallidodentate calcifications, familial idiopathic

subarachnoid hemorrhage

substantia nigra

swallow evaluation

symmetric brain lesions

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tetrahydrobiopterin

thalamic tumors

thalamus, lesion of

thalamus, lesion of-bilateral

tonic foot response

torticollis, post traumatic

toxoplasmosis, CNS

treatment failure

treatment of neurologic disorder

tremor, intention

tremor, post traumatic

tremor, postural

tremor, psychogenic

tremor, treatment of

tyrosine hydroxylase deficiency

upgaze, paralysis of

urinary incontinence

vasospasm, cerebral

viral infection

viral infection, CNS

vision, blurred

visual symptoms

visuospatial disturbance

vocal cord paralysis

walking, difficulty with

weakness, progressive

Whipple's disease

white matter disease

wide based gait

X-linked dystonia-parkinsonism syndrome

Showing articles 900 to 950 of 1676 << Previous Next >>

Physical Therapy and Parkinson's Disease:A Controlled Clinical Trial
Neurol 44:376-378, Comella,C.L.,et al, 1994

Cocaine-Induced Choreoathetoid Movements ('Crack Dancing')
Neurol 44:751-752, Daras,M.,et al, 1994

Progressive Supranuclear Palsy:Neuropathologic and Clinical Heterogeneity
Neurol 44:1015-1024, Gearing,M.,et al, 1994

The Syndrome of'Pure Akinesia'and Its Relationship to Progressive Supranuclear Palsy
Neurol 44:1025-1029, Riley,D.E.,et al, 1994

Extrapyramidalism in Alzheimer's Disease:Prevalence, Psychiatric and Neuropsychological Correlates
JNNP 57:1503-1509, Merello,M.,et al, 1994

Mitochondrial Involvement in Parkinson's Disease:The Controversy Continues
Neurol 43:2170-2172, DiMauro,S., 1993

The Motor Disorder of Multiple System Atrophy
JNNP 56:1239-1242, Quinn,N.P.&Marsden,C.D., 1993

Alternating Hemiplegia of Childhood:A Study of 10 Pts & Results of Flunarizine Treatment
Neurol 43:36-41, Silver,K.&Andermann,F., 1993

Aspartame Use in Parkinson's Disease
Neurol 43:611-613, Karstaedt,P.J.&Pincus,J.H., 1993

Nigral Dysfunction in Drug-Induced Parkinsonism:An F-dopa PET Study
Neurol 43:552-556, Burn,D.J.&Brooks,D.J., 1993

Essential Tremor and Dystonia
Neurol 43:2382-2384, Dubinsky,R.M.,et al, 1993

Gene Therapy for Neurologic Disease
Arch Neurol 50:1252-1268, Suhr,S.T.&Gage,F.H., 1993

Autosomal Dominant Parkinsoniam with Benign Course and Typical Lewy-Body Pathology
Neurol 43:2222-2227, Golbe,L.I.,et al, 1993

Risk Factors for Nursing Home Placement in Advanced Parkinson's Disease
Neurol 43:2227-2229, Goetz,C.G.&Stebbins,G.T., 1993

Fatigue in Parkinson's Disease
Neurol 43:2016-2018, Friedman,J.&Friedman,H., 1993

Cabergoline in Parkinson's Disease:Long-Term Follow-up
Neurol 43:2587-2590, Lera,G.,et al, 1993

Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993

Parkinsonism Unmasked by Verapamil
Clinical Neuropharmacol 16:263-265, Garcia-Albea,E.,et al, 1993

Neurosurgical Horizons in Parkinson's Disease
Neurol 43:1-7, Goetz,C.G.,et al, 1993

A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Arch Neurol 50:140-148, Hughes,A.J.,et al, 1993

Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993

Subcortical Dementia
BMJ 307:1-2, Dunne,F.J., 1993

Tardive Stereotype and Other Movement Disorders in Tardive Dyskinesias
Neurol 43:937-941, Stacy,M.,et al, 1993

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993

Longitudinal Exper with Botulinum Toxin Injections for Treat of Blepharospasm & Cervical Dystonia
Neurol 43:834-836, Jankovic,J.&Schwartz,K.S., 1993

Progression After Chronic Manganese Exposure
Neurol 43:1479-1483, Huang,C.C.,et al, 1993

Niemann-Pick Disease Type C:Diagnosis and Outcome in Children, with Particular Reference to Liver disease
J Pediatr 123:242-247, Kelly,D.A.,et al, 1993

Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993

Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993

Identical Twins with Similar Onset of Parkinson's Disease:A Case Report
Neurol 43:1159-1161, Pahwa,R.,et al, 1993

Parkinson's Disease:A Test of the Multifactorial Etiologic Hypothesis
Neurol 43:1173-1180, Semchuk,K.M.,et al, 1993

Environmental Causation of Parkinson's Disease
Arch Neurol 50:651-652, Rajput,A.H., 1993

The Nonenvironmental Basis for Rising Mortality from Parkinson's Disease
Arch Neurol 50:653-656, Riggs,J.E., 1993

Risk Factors for Parkinson's Disease
Neurol 43:1693-1697, 16411993., Hubble,J.P.,et al, 1993

Environmental Antecedents of Young-Onset Parkinson's Disease
Neurol 43:1150-1158, Butterfield,P.G.,et al, 1993

Olfactory Testing Differentiates Between Progressive Supranuclear Palsy & Idiopathic Parkinson's Dis
Neurol 43:962-965, Doty,R.L.,et al, 1993

Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993

Multiple System Atrophy & Prog Supranuc Palsy, Dimin Striatal D2 Dopamine Receptor Act by SPECT
Arch Neurol 50:513-516, vanRoyen,E.,et al, 1993

Faithful Fashion:Survival Status of the Brain Transplant Cure for Parkinsonism
Neurol 43:644-649, Landau,W.M., 1993

Practice Parameters:Initial Therapy of Parkinson's Disease
Report of the Quality Standards Subcommittee of AAN, Neurol 43:1296-12971993., , 1993

Clinical Experience with Controlled-Release Carbidopa/Levodopa in Parkinson's Disease
Neurol 43:677-681, Pahwa,R.,et al, 1993

Prognostic Significance of the Onset Mode in Parkinsonism
Neurol 43:829-830, Rajput,A.H.,et al, 1993

PET Imaging of the Dopamine Transporter with 11C-WIN 35, 428 Reveals Marked Declines in Mild Parkinson's Disease
Ann Neurol 34:423-431, Frost,J.J.,et al, 1993

Levodopa Improves Spatial Contrast Sensitivity in Parkinson's Disease
Arch Neurol 50:721-724, Hutton,J.T.,et al, 1993

T2 Relaxation Time in Patients with Parkinson's Disease
Neurol 43:697-700, Antonini,A.,et al, 1993

The Spectrum of Levodopa-Related Fluctuations in Parkinson's Disease
Neurol 43:1459-1464, Riley,D.E.&Lang,A.E., 1993

Alternating Hemiplegia of Childhood
J Pediatr 122:673-679, Bourgeois,M.,et al, 1993

Contrast Agent Overdose Causing Brain Retention of Contrast, Seizures, and Parkinsonism
Neurol 43:836-838, May,E.F.,et al, 1993

Treatment of Parkinson's Disease
NEJM 329:1021-1027, Calne,D.B., 1993

Botulinum Toxin in the Treatment of Writer's Cramp, A Double-Blind Study
Neurol 43:183-185, Tsui,J.K.C.,et al, 1993

Showing articles 900 to 950 of 1676 << Previous Next >>